Enter your login e-mail to the account
Search
- Chyby a úskalí terapie statiny
MUDr. Lubor Goláň
(1/2004, Main topic ) - Antibiotic therapy
MUDr. Václava Adámková
(1/2016, Review articles ) - EFFECIIVE AND SAFE PHARMACOTHERAPY FOR SENIORS
MUDr. Martin Dúbrava, CSc.
(7-8/2006, Main topic ) - Arterial thromboprophylaxis in medical and angiological practice
doc. MUDr. Peter Gavorník, PhD., mim. prof., MUDr. Angelika Bátorová, PhD.
(7-8/2009, Review articles ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - COMET – Carvedilol or Metoprolol European Trial – mortalitní studie srovnávající dva betablokátory u srdečního selhání
prof. MUDr. Jiří Vítovec, CSc., prof. MUDr. Jindřich Špinar, CSc.,
(1/2004, Spectrum ) - Modern therapy of respiratory diseases by third-generation cephalosporines
MUDr. Ján Siváček
(5/2011, Drugs & drug classes ) - NOVEL INSULINS – ANALOGS IN TYPE 2 DM TREATMENT
doc. MUDr. Emil Martinka, PhD.
(7-8/2008, Topic ) - Ceftibuten in clinic praxis
doc. MUDr. Pavol Jarčuška, PhD., MUDr. Katarína Cáriková, I. klinika detí a dorastu DFN a LF UPJŠ v Košiciach
(1/2011, Drugs & drug classes )
- Cardiovascular treatment in patients with depression: The role of beta-blockers in current practice
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Katarína Beňová, PhD.
(3/2024, Review articles ) - Interactions of tobacco smoke with psychotropic medications
MUDr. Michal Turček, PhD.
(4/2011, Review articles ) - Electroconvulsive therapy in the context of selected therapeutic guidelines
MUDr. Jozef Dragašek, PhD.
(1/2011, Review articles ) - PHARMACOTHERAPY OF DEMENTIA
doc. MUDr. Vladimír Pidrman, Ph.D.
(5/2007, Review articles ) - Postmarkentingové sledování účinnosti tabletové a kapkové formy Tiapridu v léčbě agitovanosti a neklidu ve stáří
prof. MUDr. Eva Topinková, CSc.
(4/2002, Psychopharmacology ) - Aripiprazole and Cariprazine: Similarities and Differences among Patrial Agonists
Mgr. MUDr. Jozef Dragašek, PhD., MHA, MUDr. Zuzana Vančová, PhD.
(2/2019, Review articles ) - Lurasidone: an alternative route for adverse effects
MUDr. Matúš Virčík
(4/2023, Case reports ) - New registrated antipsychotics
MUDr. Dagmar Seifertová, CSc.
(1/2001, Review articles ) - Rational combinations of antipsychotics in the treatment of schizophrenia
MUDr. Adam Nemček
(1/2022, Review articles ) - NEW SYNTHETIC DRUGS
MUDr. Tomáš Páleníček
(5/2005, Review articles ) - PITFALLS OF POLYPHARMACOTHERAPY
prof. MUDr. Eva Hadašová, CSc.
(4/2002, Review articles ) - Rare adverse drug reactions in psychiatry: Serotonin syndrome and arrhythmia torsade de pointes
MUDr. Michal Prokeš, PharmDr. Josef Suchopár
(4/2015, Review articles ) - POSSIBILITIES OF COMBINATION OF PSYCHOTHERAPEUTICS IN CLINICAL PRACTICE
prof. MUDr. Eva Češková, CSc., MUDr. Tomáš Kašpárek
(1/2003, Review articles ) - Interdisciplinary approach in dementia treatment by cholinesterase inhibitors
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, doc. MUDr. Jiří Horáček, CSc.
(3/2003, Review articles ) - Rational use of psychotropic drugs in oncology – selected indications, interactions, tips for practice
PharmDr. Jana Gregorová, MUDr. Petra Holečková, Ph.D., MBA
(4/2017, Review articles )
- Léčba demence inhibitory cholinesteráz – bezpečnost a snášenlivost v praxi
doc. MUDr. Vladimír Pidrman, Ph.D., prof. MUDr. Jaroslav Bouček, CSc., MUDr. Klára Látalová
(5/2003, From the boundary of neurology ) - INHIBITORY CHOLINESTERÁZ V LÉČBĚ ALZHEIMEROVY NEMOCI
MUDr. Martin Brunovský, Ph.D.
(2/2007, Review articles ) - News in farmacological treatment of epilepsy
prof. MUDr. Ivan Rektor, CSc., FCMA, FANA, MUDr. Ondřej Strýček
(2/2015, Main topic ) - Coffee, tea, and tobacco, interactions and other risks in patients at a neurological outpatient department
PharmDr. MVDr. Vilma Vranová, Ph.D., MUDr. Pavel Ressner, Ph.D., prof. MUDr. David Školoudík, Ph.D., FESO, FEAN
(2/2020, From the boundary of neurology )
- Microbiological aspects of otitis media acuta in children in Slovak republic
MUDr. Ingrid Urbančíková, doc. MUDr. Helena Hupková, PhD., prof. RNDr. Ján Trupl, CSc., doc. RNDr. Marián Bukovský, PhD.
(S3/2010, Original articles )
- THERAPY OF INVASIVE FUNGAL INFECTION IN IMMUNOSUPPRESSED PATIENTS
doc. MUDr. Petr Sedláček, CSc.
(1/2008, Review articles ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Použitie rastových faktorov myelopoézy v profylaxii febrilnej neutropénie
MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Ľubica Váleková, PhD., Prof. MUDr. Ján Staško, PhD.
(2/2018, Review articles ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Current treatment trends for multiple myeloma – subcutaneous administration of proteasome inhibitor
MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Janka Baňáková, MUDr. Hilda Šajgalíková, MUDr. Miroslav Šimek, PhD.
(2/2014, Review articles ) - Treatment of advance basal cell carcinoma vismodegib
MUDr. Slavomír Urbanček, PhD.
(2/2016, Drugs & drug classes )
- STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - THERAPY OF INVASIVE FUNGAL INFECTION IN IMMUNOSUPPRESSED PATIENTS
doc. MUDr. Petr Sedláček, CSc.
(2/2008, Review articles )
- Risk of geriatrics pharmacotherapy
PharmDr. Hajnalka Komjáthy, PhD.
(1/2016, Current pharmacotherapy ) - Solid dosage forms and the solubility
prof. PharmDr. Ján Kyselovič, CSc., PharmDr. Andrea Gažová, PhD.
(4/2014, Clinical pharmacy ) - Azithromycin – advantages and disadvantages of treatment
prof. RNDr. Magdaléna Kuželová, CSc.
(4/2016, Drug profile ) - Prasugrel – a novel antiplatelet agent
doc. MUDr. Otto Mayer, CSc.
(1/2011, New medicinal substances ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Contribution to questions of pharmacological treatment in the elderly
MUDr. David Suchý, Ph.D., MUDr. Milan Hromádka, Ph.D.
(4/2011, Current pharmacotherapy ) - Interaction of marihuana and hashish components
Mgr. Jaroslav Tóth, PhD., doc. PharmDr. Szilvia Czigle, PhD.
(1/2015, Phytotherapy )
- Rivaroxaban – metabolism, pharmacologic properties and drug interactions
Doc. MUDr. Tomáš Kvasnička, CSc.
(1/2019, Main topic ) - Apixaban – a new oral anticoagulant
prof. MUDr. Peter Kubisz, DrSc., doc. MUDr. Ján Staško, PhD., mim. prof., MUDr. Zuzana Jedináková
(1/2014, Drugs & drug classes ) - Amlodipin and central systolic blood pressure in hypertensives
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc., MUDr. Mária Potočárová
(2/2013, Review articles ) - Laboratórne monitorovanie liečby novými perorálnymi antikoagulanciami – spoločné odporúčania odborných spoločností
Remková A, Hulíková M, Kubisz P, Šimková I, Kamenský G, Lazúrová I, Payer J, Štvrtinová V, Turčáni P
(S4/2013, Supplement )
- Management of antibiotic treatment of intraabdominal infections
prof. MUDr. Jozef Radoňak, CSc., MUDr. Lucia Lakyová, PhD., doc. MUDr. Jana Kaťuchová, PhD.
(1/2014, Review articles )